Elite in Gaucher Disease

Shoshana Vilk-Revel

Jerusalem, JM, IL 
Elite in Gaucher Disease
Jerusalem, JM, IL 
OverviewLocationsClinical Research

Overview

Shoshana Vilk-Revel practices in Jerusalem, Israel. Ms. Vilk-Revel is rated as an Elite expert by MediFind in the treatment of Gaucher Disease. Her top areas of expertise are Gaucher Disease, Gaucher Disease Type 1, Farber Lipogranulomatosis, Splenomegaly, and Splenectomy.

Her clinical research consists of co-authoring 127 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 57 articles and participated in 1 clinical trial in the study of Gaucher Disease.

Gender
Female

Locations

Jerusalem, JM, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other
Study Phase: Phase 3
Renal Tumors Classification, Biology, and Banking Study
Renal Tumors Classification, Biology, and Banking Study
Enrollment Status: Active_not_recruiting
Publish Date: March 25, 2025
Intervention Type: Other
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease
Enrollment Status: Completed
Publish Date: December 17, 2024
Intervention Type: Drug
Study Drug: Elelyso
Study Phase: Phase 4
View 2 Less Clinical Trials

127 Total Publications

A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours.
A large long-term database of Gaucher disease patients demonstrates increased risk of lymphoma and myeloma, but not of solid tumours.
Journal: Internal medicine journal
Published: July 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vilk-Revel's expertise for a condition
ConditionClose
    View All 42 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile